These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1675036)

  • 41. The use of esmolol in whole-body hyperthermia: cardiovascular effects.
    Berry JM; Michalsen A; Nagle V; Bull JM
    Int J Hyperthermia; 1997; 13(3):261-8. PubMed ID: 9222810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of esmolol in hypertension after cardiac surgery.
    Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM
    Am J Cardiol; 1985 Oct; 56(11):49F-56F. PubMed ID: 2864849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternally administered esmolol produces fetal beta-adrenergic blockade and hypoxemia in sheep.
    Eisenach JC; Castro MI
    Anesthesiology; 1989 Nov; 71(5):718-22. PubMed ID: 2573294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique.
    Reves JG; Croughwell ND; Hawkins E; Smith LR; Jacobs JR; Rankin S; Lowe J; VanTrigt P
    J Thorac Cardiovasc Surg; 1990 Aug; 100(2):221-7. PubMed ID: 1974664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Esmolol: a short-acting titratable beta-blocker in acute myocardial ischemia.
    Viray R; Turlapaty P; Laddu A
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):153-61. PubMed ID: 2900818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Esmolol blunts postoperative hemodynamic changes after propofol-remifentanil total intravenous fast-track neuroanesthesia for intracranial surgery.
    Bilotta F; Lam AM; Doronzio A; Cuzzone V; Delfini R; Rosa G
    J Clin Anesth; 2008 Sep; 20(6):426-30. PubMed ID: 18929282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Esmolol: a novel cardioselective, titratable, intravenous beta-blocker with ultrashort half-life.
    Covinsky JO
    Drug Intell Clin Pharm; 1987 Apr; 21(4):316-21. PubMed ID: 2882993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Esmolol and the adrenergic response to perioperative stimuli.
    Murthy VS; Hwang TF; Sandage BW; Laddu AR
    J Clin Pharmacol; 1986 Mar; 26(S1):A27-A35. PubMed ID: 2870083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative efficacy and tolerance of esmolol to propranolol for control of supraventricular tachyarrhythmia.
    Morganroth J; Horowitz LN; Anderson J; Turlapaty P
    Am J Cardiol; 1985 Oct; 56(11):33F-39F. PubMed ID: 2864847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Esmolol and beta-adrenergic blockade.
    Wolman RL; Fiedler MA
    AANA J; 1991 Dec; 59(6):541-8. PubMed ID: 1686346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of esmolol on cardiac function: evaluation by noninvasive techniques.
    Iskandrian AS; Hakki AH; Laddu A
    Am J Cardiol; 1985 Oct; 56(11):27F-32F. PubMed ID: 2864845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Esmolol for the management of pediatric hypertension after cardiac operations.
    Wiest DB; Garner SS; Uber WE; Sade RM
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):890-7. PubMed ID: 9576226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade.
    Reilly CS; Wood M; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1985 Nov; 38(5):579-85. PubMed ID: 2865029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of esmolol and ASL-8123 in renal failure.
    Flaherty JF; Wong B; La Follette G; Warnock DG; Hulse JD; Gambertoglio JG
    Clin Pharmacol Ther; 1989 Mar; 45(3):321-7. PubMed ID: 2563962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction.
    Daga MK; Chaudhary M; Sharma B; Bhattacharjee J; Ghambhir DS; Arora N; Sudha R
    J Assoc Physicians India; 2003 Jul; 51():677-80. PubMed ID: 14621036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine.
    Chang KC; Lin YC; Chen JY; Chou HT; Hung JS
    Cardiology; 2002; 97(3):138-46. PubMed ID: 12077566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonthrombolytic intervention in acute myocardial infarction.
    Kirshenbaum JM
    Am J Cardiol; 1989 Jul; 64(4):25B-28B. PubMed ID: 2568748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perioperative use of esmolol.
    Reves JG; Flezzani P
    Am J Cardiol; 1985 Oct; 56(11):57F-62F. PubMed ID: 2864850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy.
    Kovac AL; Goto H; Arakawa K; Pardo MP
    Can J Anaesth; 1990 Jan; 37(1):58-62. PubMed ID: 1967227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Esmolol and intraoperative myocardial ischemia: a double-blind study.
    Neustein SM; Bronheim DS; Lasker S; Reich DL; Thys DM
    J Cardiothorac Vasc Anesth; 1994 Jun; 8(3):273-7. PubMed ID: 7914754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.